markets
markets · page 2
- CBD Market
European medical cannabis sales could reach €2.3bn by 2026
A new report projects sales for unlicensed medical cannabis in Europe.
- Pharmaceutical
DLA Piper advises on £80m acquisition
Canaccord Genuity was advised on Summerway Capital Plc’s AIM listing.
- Companies
What does Kanabo’s telehealth approach mean for UK medical cannabis?
Kanabo surprised the market with its £14m acquisition of the GP Service – so, what does this mean for the UK industry and patients?
- Companies
Alpha Blue Ocean puts more capital in cannabis
The financing will support Halo Collective’s US west coast expansion strategy.
- Companies
Akanda: first UK company listing on NASDAQ with African operations
The company will trade under the ticker AKAN.
- Pharmaceutical
Major shareholder appeals for urgent change at Oxford Cannabinoid Technologies
The appeal states there is an urgent need to address serious governance and sclerotic management issues.
- Uncategorized
Exploring California’s cannabis supply chain
Cannabis Wealth speaks to Rob Koch, director of strategy and information at California distributor, Nabis.
- Companies
Geneva-based stock exchange launched for cannabis commodities
The CBX Stock Exchange will offer “seed to shelf” transparency.
- Pharmaceutical
Positive results for cannabinoid targeting multi-billion pain market
Oxford Cannabinoid Technologies has stated it will begin Phase I clinical trials early next year.
- Adult-Use
Curaleaf reports record growth with $1.2bn revenue
The company stated it reached a significant milestone last year.
- Adult-Use
Exploring trends in THC beverages
THC beverages are growing in popularity driven by a shift away from alcohol.
- Medical
Kanabo makes £14m acquisition of telehealth GP service
Patients will now be able to access Kanabo’s medical cannabis and CBD products through The GP Service (GPS).
